Biswajit Mukherjee

4.9k total citations
115 papers, 3.7k citations indexed

About

Biswajit Mukherjee is a scholar working on Molecular Biology, Pharmaceutical Science and Biomaterials. According to data from OpenAlex, Biswajit Mukherjee has authored 115 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 36 papers in Pharmaceutical Science and 27 papers in Biomaterials. Recurrent topics in Biswajit Mukherjee's work include Advanced Drug Delivery Systems (28 papers), Nanoparticle-Based Drug Delivery (25 papers) and Advancements in Transdermal Drug Delivery (17 papers). Biswajit Mukherjee is often cited by papers focused on Advanced Drug Delivery Systems (28 papers), Nanoparticle-Based Drug Delivery (25 papers) and Advancements in Transdermal Drug Delivery (17 papers). Biswajit Mukherjee collaborates with scholars based in India, United States and Germany. Biswajit Mukherjee's co-authors include Priyanka Arora, Malay Chatterjee, Amit K. Tiwari, Ritu Gupta, Mita Chatterjee Debnath, Laboni Mondal, Pratik Banerjee, Bhabani Sankar Satapathy, Biswadip Sinha and Ruma Maji and has published in prestigious journals such as The Science of The Total Environment, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Biswajit Mukherjee

112 papers receiving 3.4k citations

Peers

Countries citing papers authored by Biswajit Mukherjee

Since Specialization

Citations

This map shows the geographic impact of Biswajit Mukherjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biswajit Mukherjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biswajit Mukherjee more than expected).

Fields of papers citing papers by Biswajit Mukherjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biswajit Mukherjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biswajit Mukherjee. The network helps show where Biswajit Mukherjee may publish in the future.

Co-authorship network of co-authors of Biswajit Mukherjee

This figure shows the co-authorship network connecting the top 25 collaborators of Biswajit Mukherjee. A scholar is included among the top collaborators of Biswajit Mukherjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biswajit Mukherjee. Biswajit Mukherjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High Resolution Nerve Ultrasound in the Diagnosis of Pure Neuritic Leprosy 2025 ·Journal of Clinical Ultrasound ·(unknown), (unknown), (unknown), Anurag Srivastava, Biswajit Mukherjee, (unknown), (unknown), (unknown), Neha Rani, Itu Singh, (unknown)	0
2	Molecular insights into the antineoplastic potential of apigenin and its derivatives: paving the way for nanotherapeutic innovations 2025 ·Expert Opinion on Drug Delivery ·Debasmita Dutta, (unknown), (unknown), Shahnaz Begum, (unknown), Biswajit Mukherjee	0
3	Folic acid-tripeptide-conjugated synthetic biodegradable nanoparticle-loaded with Ormeloxifene potentially inhibited breast cancer xenograft tumor 2024 ·Journal of Drug Delivery Science and Technology ·Ramkrishna Sen, (unknown), (unknown), Biswajit Mukherjee	2
4	EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment 2024 ·Journal of Biomedical Science ·Debasmita Dutta, (unknown), (unknown), Jun Hyoung Park, Chinmay Chowdhury, Mohiuddin Quadir, Soumyabrata Banerjee, (unknown), (unknown), Nayim Sepay, (unknown), Benny Abraham Kaipparettu, Biswajit Mukherjee	9
5	Phosphorothioated amino-AS1411 aptamer functionalized stealth nanoliposome accelerates bio-therapeutic threshold of apigenin in neoplastic rat liver: a mechanistic approach 2023 ·Journal of Nanobiotechnology ·(unknown), (unknown), Ramkrishna Sen, Debasmita Dutta, Biswajit Mukherjee, (unknown), (unknown)	22
6	<p>CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice</p> 2019 ·International Journal of Nanomedicine ·Laboni Mondal, Biswajit Mukherjee, Kaushik Das, (unknown), Debasmita Dutta, (unknown), (unknown), Raghuvir H. Gaonkar, Mita Chatterjee Debnath	33
7	Lipid nanocarrier-based transport of docetaxel across the blood brain barrier 2016 ·RSC Advances ·Bhabani Sankar Satapathy, Biswajit Mukherjee, Rinku Baishya, Mita Chatterjee Debnath, (unknown), Ruma Maji	29
8	Early Stage HIV Management and Reduction of Stavudine-Induced Hepatotoxicity in Rats by Experimentally Developed Biodegradable Nanoparticles 2016 ·AAPS PharmSciTech ·Saikat Ghosh, Laboni Mondal, Samrat Chakraborty, Biswajit Mukherjee	12
9	Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer 2015 ·Current Cancer Drug Targets ·(unknown), Biswajit Mukherjee, Ruma Maji, Bhabani Sankar Satapathy	22
10	Is Type 2 Diabetes Mellitus a Predisposal Cause for Developing Hepatocellular Carcinoma? 2015 ·Current Diabetes Reviews ·Biswajit Mukherjee, (unknown), Samrat Chakraborty, Bhabani Sankar Satapathy, (unknown), Tapan Kumar Shaw	11
11	DEVELOPMENT AND CHARACTERISATION OF LIPOSOMAL DELIVERY SYSTEM CONTAINING DIURETIC DRUG TORSEMIDE 2013 ·Indo American Journal of Pharmaceutical Research ·(unknown), Biswajit Mukherjee	1
12	Colloidal gold-loaded, biodegradable, polymer-based stavudine nanoparticle uptake by macrophages: an in vitro study 2012 ·International Journal of Nanomedicine ·Biswajit Mukherjee, (unknown), (unknown), Paramita Paul, (unknown), Ajeet Kumar, Laboni Mondal, Chowdhury Faiz Hossain, Ruma Maji	30
13	Formulation development andin vitroevaluation of solidified self-microemulsion in the form of tablet containing atorvastatin calcium 2012 ·Drug Development and Industrial Pharmacy ·Kazi Asraf Ali, Biswajit Mukherjee, Amal Kumar Bandyopadhyay	7
14	Stability analysis of primary emulsion using a new emulsifying agent gum odina 2010 ·Natural Science ·Amalesh Samanta, Durbadal Ojha, Biswajit Mukherjee	17
15	Plankton diversity and dynamics in a polluted eutrophic lake, Ranchi 2010 ·Journal of Environmental Biology ·Biswajit Mukherjee, (unknown), Debasis Mukherjee	27
16	Nefopatli containing transdermal-matrix patches: Based on pressure-sensitive adhesive polymers 2006 ·Biswajit Mukherjee, Surajit Das, (unknown), Buddhadev Layek	10
17	Preparation and Evaluation of Verapamil Hydrochloride Microcapsules 2005 ·American Journal of Therapeutics ·Biswajit Mukherjee, (unknown), (unknown), (unknown)	12
18	A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation 2004 ·European Journal of Pharmaceutics and Biopharmaceutics ·Biswajit Mukherjee, (unknown), Ritu Gupta, (unknown), Amit K. Tiwari, Priyanka Arora	111
19	Chemical and pharmacological evaluation of different ayurvedic preparations of iron 1999 ·Journal of Ethnopharmacology ·(unknown), Tuhin Kanti Biswas, Partha Debnath, Achintya Saha, Uttam Kumar Chowdhury, (unknown), Supatra Sen, Biswajit Mukherjee	42
20	Comparative Patterns of Hepatic Drug Metabolizing Enzymes and Their Possible Correlation with Chromosomal Aberrations in Transplantable Murine Lymphoma: a Time Course Study 1994 ·Cancer Investigation ·(unknown), Biswajit Mukherjee, (unknown), Malay Chatterjee	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact